Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 cr

Source: Economics Times Lupin Atlantis Holdings SA, Switzerland, a wholly-owned subsidiary of the company, has signed an asset purchase agreement with Sanofi, a French multinational pharmaceutical and healthcare company, for the purpose, Lupin said in a regulatory filing. New Delhi: Home-grown pharma major Lupin Ltd on Friday said it acquired a portfolio of established products in Europe […]

US FDA declines to approve Zealand Pharma’s drug for low blood sugar in Infants

The company is seeking regulatory approval for the use of the drug in patients aged seven days or older with CHI, a genetic disorder in which the insulin cells of the pancreas secrete too much insulin. New Zealand: The U.S. Food and Drug Administration (FDA) declined to approve Zealand Pharma‘s drug for the prevention and treatment of low […]

Notices sent to12 firms in Himachal over quality issues

Source: Hindustan Times The samples of medicines manufactured in Himachal whose samples have failed include medicines and injections for the treatment of cancer, heart disease, infection, fever, vomiting, gastric, edema, cholesterol, pneumonia and stomach worms The Central Drugs Standard Control Organisation (CDSCO) has exposed a grave lapse in pharmaceutical quality control. As many as 14 […]

Why pharma majors are rushing to put anti-obesity drugs on Indian shelves

Source: Business Today Indian pharmaceutical companies are hungry for the next frontier: drugs to fight obesity, a condition that has become the biggest worry for the urban well-off as they gorge on calorie-dense food (read: junk and fast food) and lead unhealthy lifestyles. Anti-obesity drugs are big business in the West, where obesity has reached […]